Vimarsana
Biggest News Aggregation in the World

Javier Muniz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Javier Muniz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Javier Muniz Today - Breaking & Trending Today

Ibogaine long shot for FDA approval, heart expert warns Kentucky opioid commission - Vimarsana News

Ibogaine long shot for FDA approval, heart expert warns Kentucky opioid commission

In a session focused on challenges of getting the psychedelic drug ibogaine approved by the Food and Drug Administration for treating addiction with help of the state’s opioid settlement funds,

Ibogaine long shot for FDA approval, heart expert warns Kentucky opioid commission - Vimarsana News

Ibogaine long shot for FDA approval, heart expert warns Kentucky opioid commission

In a session focused on challenges of getting the psychedelic drug ibogaine approved by the Food and Drug Administration for treating addiction with help of the state’s opioid settlement funds,

Sand City's Art Park now houses the School of Sacred Rhythms, a drumming workshop for all. | 831 (Tales from the Area Code) - Vimarsana News

Sand City's Art Park now houses the School of Sacred Rhythms, a drumming workshop for all. | 831 (Tales from the Area Code)

“This is going to be a funshop,” Sanga of The Valley tells a group gathered on a gray and chilly Saturday in Sand City’s Art Park. The participants – mostly

L.A. hospital cuts hospital stays, adds video-call exams - Vimarsana News

L.A. hospital cuts hospital stays, adds video-call exams

More than 500 patients have participated in L.A. General's Safer at Home program, cared for remotely by several dozen nurses and five physicians.

Experimental Psychedelic Therapy Returns to the V.A. - Vimarsana News

Experimental Psychedelic Therapy Returns to the V.A.

A series of clinical trials using MDMA and psilocybin mushrooms represent a resurrection of promising research abandoned in the 1960s.